Implementation of step sectioning in the examination of sentinel lymph nodes to improve the detection of micrometastases in breast cancer patients
MARIT VALLA
Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway
Search for more papers by this authorPATRICIA GJERTRUD MJØNES
Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway
Search for more papers by this authorSYNNE KNOPP
Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway
Search for more papers by this authorMARIT VALLA
Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway
Search for more papers by this authorPATRICIA GJERTRUD MJØNES
Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway
Search for more papers by this authorSYNNE KNOPP
Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway
Search for more papers by this authorAbstract
Valla M, Mjønes PG, Knopp S. Implementation of step sectioning in the examination of sentinel lymph nodes to improve the detection of micrometastases in breast cancer patients. APMIS 2012; 120: 521–28.
The object of this study was to examine whether a new protocol for examination of sentinel lymph nodes (SLNs) would lead to the detection of more metastases. Sections of 1 mm would identify most SLN macrometastases, and step sections at intervals of 200–250 μm would identify most micrometastases. A total of 111 breast cancer patients who underwent the SLN procedure at St. Olavs University Hospital in Trondheim, Norway in 2008 were included in the study group. Their SLNs were processed according to a new standardized protocol with sections of 2–3 mm being step sectioned at intervals of 200–250 μm. A total of 109 breast cancer patients undergoing the SLN procedure in 2007 were used as a reference group. Metastases were found in 29% of the cases, compared with 26% in the reference group. Step sectioning of SLNs revealed metastases in five cases initially found to be negative. The metastases of the study group were smaller, with a median value of 1.25 mm compared with 4.25 mm in the reference group. Step sectioning led to the detection of metastases in SLNs initially found to be negative. The median size of the metastases was considerably smaller in the study group than in the reference group.
References
- 1Chen SL, Iddings DM, Scheri RP, Bilchic AJ. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin2006; 56: 292–309.
- 2Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg1995; 222: 394–9.
- 3Kell MR, Burke JP, Barry M, Morrow M. Outcome of axillary staging in early breast cancer: a meta-analysis. Breast Cancer Res Treat2010; 120: 441–7.
- 4Helms G, Kühn T, Moser L, Remmel E, Kreienberg R. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection – data from a prospective randomised trial. Eur J Surg Oncol2009; 35: 696–701.
- 5Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al.Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst2006; 98: 599–609.
- 6Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, et al.Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol2005; 23: 4312–21.
- 7Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer2003; 89: 648–52.
- 8Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN, et al.Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. J Clin Oncol2010; 28: 3929–36.
- 9 LH Sobin, MK Gospodarowicz, C Wittekind editors. TNM Classification of Malignant Tumours. 7th edn, Oxford: Wiley-Blackwell, 2009.
- 10de Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer1992; 66: 523–7.
- 11Rosen PP, Saigo PE, Braun DW, Weathers E, Fracchia AA, Kinne DW. Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg1981; 194: 585–91.
- 12Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, et al.Size of breast cancer metastases in axillary l2mph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol2005; 23: 1379–89.
- 13Kuijt GP, Voogd AC, van de Poll-Franse LV, Scheijmans LJ, van Beek MW, Roumen RM. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol2005; 31: 500–5.
- 14Susnik B, Frkovic-Grazio S, Bracko M. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up. Ann Surg Oncol2004; 11: 568–72.
- 15Andersson Y, Frisell J, Sylvan M, de Boniface J, Bergkvist L. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol2010; 28: 2868–73.
- 16de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, Adang EM, et al.Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med2009; 361: 653–63.
- 17de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst2010; 102: 410–25.
- 18Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG, McGuckin MA. Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis. Am J Surg Pathol2002; 26: 1286–95.
- 19Querzoli P, Pedriali M, Rinaldi R, Lombardi AR, Biganzoli E, Boracchi P, et al.Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res2006; 12: 6696–701.
- 20Tan LK, Giri D, Hummer AJ, Penageas KS, Brogi E, Norton L, et al.Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol2008; 26: 1803–9.
- 21Leidenius MH, Vironen JH, Heikkilä PS, Joensuu H. Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol2010; 17: 254–62.
- 22Cox CE, Kiluk JV, Riker AI, Cox JM, Allred N, Ramos DC, et al.Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg2008; 206: 261–8.
- 23Pugliese MS, Beatty JD, Tickman RJ, Allison KH, Atwood MK, Szymonifka J, et al.Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories. Ann Surg Oncol2009; 16: 113–20.
- 24Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, et al.Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol2004; 57: 695–701.
- 25Pepels MJ, Vestjens JH, de Boer M, Smidt M, van Diest PJ, Borm GF, et al.Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat2011; 125: 301–13.
- 26Treseler P. Pathologic examination of the sentinel lymph node: what is the best method?Breast J2006; 12: 143–51.
- 27Cserni G. A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol2004; 57: 467–71.
- 28Van Diest PJ, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, et al.Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology1999; 35: 14–8.
- 29Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, et al.Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer2003; 39: 1654–67.
- 30Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol2002; 55: 926–31.
- 31Torrenga H, Rahusen FD, Meijer S, Borgstein PJ, van Diest PJ. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol2001; 54: 550–2.
- 32Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg1994; 220: 391–8.
- 33Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, et al.Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg2001; 233: 51–9.
- 34Clarke D, Newcombe RG, Mansel RE. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol2004; 11: 211S–5S.
- 35Cody HS 3rd, Hill AD, Tran KN, Brennan MF, Borgen PI. Credentialing for breast lymphatic mapping: how many cases are enough?Ann Surg1999; 229: 723–6.
- 36Tafra L. The learning curve and sentinel node biopsy. Am J Surg2001; 182: 347–50.
- 37Derossis AM, Fey J, Yeung H, Yeh SD, Heerdt AS, Petrek J, et al.A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg2001; 193: 473–8.
- 38Meyer JS.
Sentinel lymph node biopsy: strategies for pathologic examination of the specimen.
J Surg Oncol1998; 69: 212–8.
10.1002/(SICI)1096-9098(199812)69:4<212::AID-JSO4>3.0.CO;2-V CAS PubMed Web of Science® Google Scholar
- 39Purdie CA.
Sentinel lymph node biopsy: review of the literature and guidelines for pathological handling and reporting.
Curr Diagn Pathol2007; 13: 106–15.
10.1016/j.cdip.2006.12.005 Google Scholar